271 related articles for article (PubMed ID: 11925436)
1. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.
Fabbro M; Rodriguez JA; Baer R; Henderson BR
J Biol Chem; 2002 Jun; 277(24):21315-24. PubMed ID: 11925436
[TBL] [Abstract][Full Text] [Related]
2. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
3. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
Brodie KM; Mok MTS; Henderson BR
Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
[TBL] [Abstract][Full Text] [Related]
4. Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.
Brodie KM; Henderson BR
J Biol Chem; 2012 Mar; 287(10):7701-16. PubMed ID: 22262852
[TBL] [Abstract][Full Text] [Related]
5. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
Brodie KM; Henderson BR
Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
[TBL] [Abstract][Full Text] [Related]
7. Nuclear targeting and cell cycle regulatory function of human BARD1.
Schüchner S; Tembe V; Rodriguez JA; Henderson BR
J Biol Chem; 2005 Mar; 280(10):8855-61. PubMed ID: 15632137
[TBL] [Abstract][Full Text] [Related]
8. BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis.
Tembe V; Henderson BR
J Biol Chem; 2007 Jul; 282(28):20513-22. PubMed ID: 17510055
[TBL] [Abstract][Full Text] [Related]
9. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
10. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
11. Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking.
Henderson BR
Bioessays; 2005 Sep; 27(9):884-93. PubMed ID: 16108063
[TBL] [Abstract][Full Text] [Related]
12. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
Au WW; Henderson BR
Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
[TBL] [Abstract][Full Text] [Related]
13. DNA damage induces p53-dependent BRCA1 nuclear export.
Feng Z; Kachnic L; Zhang J; Powell SN; Xia F
J Biol Chem; 2004 Jul; 279(27):28574-84. PubMed ID: 15087457
[TBL] [Abstract][Full Text] [Related]
14. The in vivo dynamic organization of BRCA1-A complex proteins at DNA damage-induced nuclear foci.
Mok MT; Henderson BR
Traffic; 2012 Jun; 13(6):800-14. PubMed ID: 22420687
[TBL] [Abstract][Full Text] [Related]
15. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.
Rodriguez JA; Au WW; Henderson BR
Exp Cell Res; 2004 Feb; 293(1):14-21. PubMed ID: 14729053
[TBL] [Abstract][Full Text] [Related]
17. The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci.
Au WW; Henderson BR
J Biol Chem; 2005 Feb; 280(8):6993-7001. PubMed ID: 15569676
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.
Jefford CE; Feki A; Harb J; Krause KH; Irminger-Finger I
Oncogene; 2004 Apr; 23(20):3509-20. PubMed ID: 15077185
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
